Research Use Only — Confirm to Continue

OptimalDosages.com publishes reference material for laboratory and educational use. Nothing here is medical advice, a prescription, or a recommendation for human administration.

By continuing you confirm you are 21 or older and that you are accessing this material in a research or educational capacity.

Research Use Only · Dosing data compiled from published literature · Not for human or veterinary use

NAD+ Dosage & Reconstitution

Nicotinamide adenine dinucleotide. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: limited.

1Set Up Your Mix

100 mg/mL · 100000 mcg/mL
All answers assume a standard 1 mL U-100 syringe, where 1 unit = 0.01 mL. That is the usual insulin syringe and the one every number here is based on.

Your Answer — NAD+Your Answer

100Draw To This Line
1That's This Many mL
5Doses In The Vial
0102030405060708090100 U-100 syringe · 1 mL · 100 units draw to 100
500 mg ÷ 5 mL = 100 mg/mL  →  100 mg ÷ 100 mg/mL = 1 mL  →  × 100 = 100 units
Looks good. Draw to 100 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 5 doses.

2Week-By-Week Plan — NAD+

Start low, work up
WhenDoseHow OftenHow Many mLDraw ToNumber Of DosesPeptide Used
Low reported (SC) 50 mg 1× daily 0.5 mL 50 u 10 doses
Standard (SC) 100 mg 1× daily 1 mL 100 u 5 doses
Upper reported range250–1000 mg over several hoursperiodic Set by body weight — can't be turned into a single amount to draw
Weeks until the top dose
2 weeks
Peptide used getting there
700 mg
Vials you'll need
2 × 500 mg
Once you're at the top dose
2800 mg / 4 wk · 5.6 vials
Where this plan came from
Built from this peptide's dose range
Where this came from: Built from the doses listed for this peptide below — start at the lowest and step up, using the studies cited on this page. Nobody publishes a week-by-week plan for this peptide, so we built one: the doses are the researched ones shown below, and we simply put them in order from lowest to highest. Treat it as a starting point, not an official schedule.

3Common Doses — NAD+

worked out for your mix
LevelDoseHow OftenHow Many mLDraw ToDoses In Vial
Weeks 1–2 50 mg daily 0.5 mL 50 u 14 700 mg
Week 3 onward
per 4 weeks from here on
100 mg daily 1 mL 100 u 28 2800 mg
Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About NAD+About This Peptide

Mitochondrial
Also known as
Nicotinamide adenine dinucleotide
Class
Mitochondrial
Route
Subcutaneous
Half-life
Rapid clearance
Evidence tier
Limited

A coenzyme rather than a peptide. Direct NAD+ administration is bioavailability-limited and often poorly tolerated (stinging, flushing, nausea). Most rigorous human research uses precursors — NR or NMN — rather than NAD+ itself.

Buy NAD+this peptide

Opens optimal-pep.com in a new tab

Where These Numbers Come From

Limited — Sparse, single-programme, or community-reported figures
NAD+ metabolism and its roles in cellular processes during ageing Covarrubias AJ, et al. Nature Reviews Molecular Cell Biology, 2021
The definitive current review of NAD+ biology and where the evidence actually stands.
Find on PubMed ↗
Nicotinamide riboside supplementation in humans — dose escalation Trammell SAJ, et al. Nature Communications, 2016
Human PK for the precursor route, which is far better characterised than direct NAD+.
Find on PubMed ↗
Chronic nicotinamide riboside supplementation is well tolerated Martens CR, et al. Nature Communications, 2018
Human safety and tolerability at defined doses.
Find on PubMed ↗

Newest Studies —

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

More peptides

Browse the full catalogue, or jump to a neighbouring compound.

FOXO4-DRI

A senolytic peptide that disrupts the FOXO4–p53 interaction, selectively triggering apoptosis in senescent cells. The research dat…

MOTS-c

A mitochondrial-derived peptide acting via AMPK on insulin sensitivity and metabolic homeostasis. Genuinely interesting mechanism …

All 71 peptides

Every compound compared in one table: dose range, how often, half-life and evidence tier.